VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing

Genome Research

Volumn 22, Issue 3, 2012, Pages 568-576

  Koboldt, Daniel C ^a   Zhang, Qunyuan ^a   Larson, David E ^a   Shen, Dong ^a   McLellan, Michael D ^a   Lin, Ling ^a   Miller, Christopher A ^a   Mardis, Elaine R ^a,b,c   Ding, Li ^a,b   Wilson, Richard K ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN CCNE1; PROTEIN NF1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; COPY NUMBER VARIATION; CORRELATION MATRIX DIAGONAL SEGMENTATION ALGORITHM; EXOME; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE SEQUENCE; GENETIC ALGORITHM; GENOTYPE; HUMAN; ONCOGENE; ONCOGENE MYC; OVARY CARCINOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; VALIDATION PROCESS;

ALGORITHMS; COMPUTATIONAL BIOLOGY; DNA COPY NUMBER VARIATIONS; EXOME; FEMALE; GENOMICS; GENOTYPE; GERM-LINE MUTATION; HUMANS; INTERNET; MUTATION; NEOPLASMS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFTWARE;

EID: 84863229597     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.129684.111     Document Type: Article

References (30)

1. Abyzov A, Urban AE, Snyder M, Gerstein M. 2011. CNVnator: An approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. Genome Res 21: 974-984.
2. Alam SM, Fujimoto J, Jahan I, Sato E, Tamaya T. 2008. Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers. Br J Cancer 98: 845-851. (Pubitemid 351272606)
3. Alkan C, Kidd JM, Marques-Bonet T, Aksay G, Antonacci F, Hormozdiari F, Kitzman JO, Baker C, Malig M, Mutlu O, et al. 2009. Personalized copy number and segmental duplication maps using next-generation sequencing. Nat Genet 41: 1061-1067.
4. Bainbridge MN, Wang M, Burgess DL, Kovar C, Rodesch MJ, D'Ascenzo M, Kitzman J,Wu YQ, Newsham I, Richmond TA, et al. 2010. Whole exome capture in solution with 3 Gbp of data. Genome Biol 11: R62. doi: 10.1186/gb-2010-11-6-r62.
5. Bast RC Jr, Hennessy B, Mills GB. 2009. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9: 415-428.
6. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, et al. 2010. The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905.
7. Bowtell DD. 2010. The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer 10: 803-808.
8. Campbell PJ, Stephens PJ, Pleasance ED, O'Meara S, Li H, Santarius T, Stebbings LA, Leroy C, Edkins S, Hardy C, et al. 2008. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 40: 722-729. (Pubitemid 351748860)
9. Cancer Genome Atlas Research Network. 2011. Integrated genomic analyses of ovarian carcinoma. Nature 474: 609-615.
10. Chiang DY, Getz G, Jaffe DB, O'Kelly MJ, Zhao X, Carter SL, Russ C, Nusbaum C, Meyerson M, Lander ES. 2009. High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat Methods 6: 99-103.
11. Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW, Harris CC, McLellan MD, Fulton RS, Fulton LL, et al. 2010. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464: 999-1005.
12. International Cancer Genome Consortium. 2010. International network of cancer genome projects. Nature 464: 993-998.
13. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu YT, Roskin KM, Schwartz M, Sugnet CW, Thomas DJ, et al. 2003. The UCSC Genome Browser Database. Nucleic Acids Res 31: 51-54. (Pubitemid 36150331)
14. Koboldt DC, Miller RD, Kwok PY. 2006. Distribution of human SNPs and its effect on high-throughput genotyping. Hum Mutat 27: 249-254.
15. Koboldt DC, Chen K, Wylie T, Larson DE, McLellan MD, Mardis ER, Weinstock GM,Wilson RK, Ding L. 2009. VarScan: Variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25: 2283-2285.
16. Ku CS, Naidoo N, Pawitan Y. 2011. Revisiting Mendelian disorders through exome sequencing. Hum Genet 129: 351-370.
17. Kumar SR, Masood R, Spannuth WA, Singh J, Scehnet J, Kleiber G, Jennings N, Deavers M, Krasnoperov V, Dubeau L, et al. 2007. The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome. Br J Cancer 96: 1083-1091. (Pubitemid 46608305)
18. Larson DE, Harris CC, Chen K, Koboldt DC, Ding L, Wilson RK. 2011. SomaticSniper: Identification of somatic point mutations in whole genome sequencing data. Bioinformatics (in press). doi: 10.1093/ bioinformatics/btr665.
19. Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, Dooling D, Dunford-Shore BH, McGrath S, Hickenbotham M, et al. 2008. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456: 66-72.
20. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath SD, et al. 2009. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 361: 1058-1066.
21. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, Shaffer T, Wong M, Bhattacharjee A, Eichler EE, et al. 2009. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461: 272-276.
22. Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA, Venkitaraman AR. 1998. Involvement of Brca2 in DNA repair. Mol Cell 1: 347-357. (Pubitemid 128378883)
23. Safran M, Solomon I, Shmueli O, Lapidot M, Shen-Orr S, Adato A, Ben-Dor U, Esterman N, Rosen N, Peter I, et al. 2002. GeneCards 2002: towards a complete, object-oriented, human gene compendium. Bioinformatics 18: 1542-1543. (Pubitemid 35414549)
24. Seshan VE, Olshen AB. 2010. DNAcopy: A package for analyzing DNA copy data. BioPerl. http://bioconductor.org/help/bioc-views/release/bioc/html/ DNAcopy.html.
25. Stratton MR. 2011. Exploring the genomes of cancer cells: progress and promise. Science 331: 1553-1558.
26. Teer JK, Bonnycastle LL, Chines PS, Hansen NF, Aoyama N, Swift AJ, Abaan HO, Albert TJ, Margulies EH, Green ED, et al. 2010. Systematic comparison of three genomic enrichment methods for massively parallel DNA sequencing. Genome Res 20: 1420-1431.
27. Wei X,Walia V, Lin JC, Teer JK, Prickett TD, Gartner J, Davis S, Stemke-Hale K, Davies MA, Gershenwald JE, et al. 2011. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 43: 442-446.
28. Xu X, Weaver Z, Linke SP, Li C, Gotay J,Wang XW, Harris CC, Ried T, Deng CX. 1999. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 3: 389-395. (Pubitemid 29290679)
29. Yoon S, Xuan Z, Makarov V, Ye K, Sebat J. 2009. Sensitive and accurate detection of copy number variants using read depth of coverage. Genome Res 19: 1586-1592.
30. Zhang Q, Ding L, Larson DE, Koboldt DC, McLellan MD, Chen K, Shi X, Kraja A, Mardis ER, Wilson RK, et al. 2010. CMDS: a population-based method for identifying recurrent DNA copy number aberrations in cancer from high-resolution data. Bioinformatics 26: 464-469.